PolarityTE, Inc. (COOL) SkinTE Data - Future of Skin Regeneration Conference Call June 8, 2017 4:30 PM ET
Executives
Ned Swanson - Chief Operating Officer
Denver Lough - Chairman and CEO
Stephen Milner - Chief Clinical Officer
Analysts
Elemer Piros - Cantor
Robert Obraitis - Cambridge Investment Research
Matt Hewitt - Craig-Hallum Capital Group
Operator
Greetings, and welcome to the PolarityTE Conference Call at the Future of Skin Regeneration Conference. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Dr. Ned Swanson. Thank you, you may begin.
Ned Swanson
Thank you, operator, and good afternoon, everyone. This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These statements are based upon the current beliefs and expectations of our management and are subject to risks and uncertainties.
Actual results may differ materially from those set forth in, contemplated by, or underlying the forward-looking statements based on factors described in this conference call and in our reports filed with the Securities and Exchange Commission, including our Form 10-K for the year ended October 31, 2016, and our most recent 10-Q. We do not undertake to update or revise any forward-looking statements except as maybe required by the company’s disclosure obligations, and the filing that makes with the Securities and Exchange Commission under Federal Securities Laws.
With that, I’ll turn the call over to Dr. Denver Lough, PolarityTE’s Chairman and CEO.
Denver Lough
Thank you, Ned, and thank you to all of the shareholders, supporters, and those on this call for joining us today to discuss some very exciting material data and ultimate vision as it relates to PolarityTE and our regenerative medicine platform technology. Before I continue
- Read more current RGTPQ analysis and news
- View all earnings call transcripts